Lack of CD54 Expression and Mutation of p53 Gene Relate to the Prognosis of Childhood Burkitt's Lymphoma

References

• Burkitt D. A sarcoma involving the jaws in African children. Br. J. Surg 1958; 46: 218–223
   PubMed Web of Science ®Google Scholar
• Patte C, Philip T, Rodary C, Zucker J C, Behrendt H, Gentet J C, Lamagnere J P, Otten J, Dufillot D, Pein F, Caillou B, Lemerle J. High survival rate in advanced-stage cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French pediatric oncology society of arandomized trial of 216 children. J. Clin. Oncol 1991; 9: 123–132
   PubMed Web of Science ®Google Scholar
• Ziegler J L. Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. N. Engl. J. Med 1977; 297: 76–80
   Web of Science ®Google Scholar
• Philip T, Hartmann O, Pinkeiton R, Zucker J M, Gentet J C, Lamagnere J P, Berhendt H, Perel Y, Otten J, Lutz P, Rodary C, Caillou B, Bayle C, Chauvin F, Patte C. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: a report from the Societe Francaise d'Oncologie Pediatrique. Blood 1993; 81: 2003–2006
   PubMed Web of Science ®Google Scholar
• Kiyokawa N, Kokai Y, Kikuchi K, Fujita H, Hata J I, Fujimoto J. Distinctive pattern of expression of activation and resting B cell antigens on normal and neoplastic human B cells: immunophenotypic heterogeneity in some lymphomas. Leukemia Lymphoma 1990; 3: 119–126
   PubMed Web of Science ®Google Scholar
• Kiyokawa N, Kokai Y, Ishimoto K, Fujita H, Fujimoto J, Hata J I. Characterization of common acute lymphoblastic antigen (CD10) as an activation molecule on mature human B cells. Clin. Exp. Immunol 1990; 79: 322–327
   PubMed Web of Science ®Google Scholar
• Hollstein M, Sidransky D, Vogelstein B, Harris C C. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Farrel P J, Allan J A, Shanahan F, Vousden K H, Crook T. p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J 1991; 10: 2879–2887
   PubMed Web of Science ®Google Scholar
• Gaidano G, Ballerini P, Gong J Z, Inghirami G, Neri A, Newcomb E W, Magrath I T, Knowles D M, Dalla-Favera R. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar
• Imamura J, Miyoshi I, Koeffler P. p53 in hematologic malignancies. Blood 1994; 84: 2412–2421
   PubMed Web of Science ®Google Scholar
• Kokai Y, Ishi Y, Kikuchi K. Characterization of two distinct antigens expressed on either resting or activated human B cells as defined by monoclonal antibodies. Clin. Exp. Immunol 1986; 64: 382–391
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Ishimoto K, Kiyokawa N, Tanaka S, Ishii E, Hata J. Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related. Hybridoma 1988; 7: 227–236
   PubMed Web of Science ®Google Scholar
• Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M. Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction—single strand conformation polymorphism. Cancer Res 1992; 52: 5061–5064
   PubMed Web of Science ®Google Scholar
• Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874–879
   PubMed Web of Science ®Google Scholar
• Murphy S B. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults. Semin. Oncol 1980; 7: 332–339
   PubMed Web of Science ®Google Scholar
• Maio M, Del-Vecchio L. Expression and functional role of CD54/Intercellular Adhesion Molecule-1 (ICAM-1) on human blood cells. Leuk Lymphoma 1992; 8: 23–33
   PubMed Web of Science ®Google Scholar
• Springer T A. Adhesion receptors of the immune system. Nature 1990; 346: 425–434
   PubMed Web of Science ®Google Scholar
• Horst E, Radaszkiewicz T, Hooftman-den-Otter A, Pieters R, van-Dongen J J, Meijer C J, Pals S T. Expression of the leucocyte integrin LFA-1 (CD 11a/CD18) and its Iigand ICAM-1 (CD54) in lymphoid malignancies is related to lineage derivation and stage of differentiation but not to tumor grade. Leukemia 1991; 5: 848–53
   PubMed Web of Science ®Google Scholar
• Ree H J, Khan A A, Elsakr M, Liau S, Teplitz C. Intercellular adhesion molecule-1 (ICAM-1) staining of reactive and neoplastic follicles. ICAM-1 expression of neoplastic follicle differs from that of reactive germinal center and is independent of follicular dendritic cells. Cancer 1993; 71: 2817–22
   PubMed Web of Science ®Google Scholar
• Petrasch S, Kosco M, Schmitz J, Wacker H H, Brittinger G. Follicular dendritic cells in non-Hodgkin-lymphoma express adhesion molecules complementary to ligands on neoplastic B-cells. Br. J. Haematol 1992; 82: 695–700
   PubMed Web of Science ®Google Scholar
• Nozawa Y, Yamaguchi Y, Tominaga K, Hojo H, Abe M, Wakasa H. Expression of leukocyte adhesion molecules (ICAM-1 /LFA-1) related to clinical behaviour in B cell lymphomas. Hematol. Oncol 1992; 10: 189–94
   PubMed Web of Science ®Google Scholar
• Kitsuki H, Uchiyama A, Yoshida T, Torisu M. OK-432-induced enhancement of ICAM-1 expression on tumor cells positively correlates to therapeutic effects for malignant effusion. Clin. Immunol. Immunopathol 1994; 71: 89–95
   PubMedGoogle Scholar
• Koopman G, Heider K H, Horst E, Adolf G R, van den Berg F, Ponta H, Herrlich P, Pals S T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med 1993; 177: 897–904
   PubMed Web of Science ®Google Scholar
• Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood 1994; 84: 2391–2411
   PubMed Web of Science ®Google Scholar
• Xiong Y, Hannon G J, Zhang H, Casso D, Kobayashi R, Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 1993; 366: 701–704
   PubMed Web of Science ®Google Scholar
• Harper J W, Adami G R, Wei N, Keyomarsi K, Elledge S J. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805–816
   PubMed Web of Science ®Google Scholar
• El-Deiry W S, Tokino T, Velculescu V E, Levy D B, Parsons R, Trent J M, Lin D, Mercer W E, Kinzler K W, Vogelstein B. WAF-1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825
   PubMed Web of Science ®Google Scholar
• Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai J L, Vanrumbeke M, Loucheux-Lefebvre M H, Bauters F, Berger R, Kerckaert J P. Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. Leukemia 1992; 6: 42–46
   PubMed Web of Science ®Google Scholar
• Wada M, Bartram C R, Nakamura H, Hachiya M, Chen D L, Borenstein J, Miller C W, Ludwig L, Hansen-Hagge T E, Ludwig W D, Reiter A, Mizoguchi H, Koeffler H P. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood. Blood 1993; 82: 3163–3169
   PubMed Web of Science ®Google Scholar
• Bhatia K G, Gutierrez M I, Huppi K, Siwarski D, Magrath I T. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors. Cancer Res 1992; 52: 4273–4276
   PubMed Web of Science ®Google Scholar
• Wada H, Asada M, Nakazawa S, Itoh H, Kobayashi Y, Inoue T, Fukumuro K, Chan L C, Sugita K, Hanada R, Akuta N, Kobayashi N, Mizutani S. Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia 1994; 8: 53–9
   PubMed Web of Science ®Google Scholar
• Rabbits T H. Chromosomal translocations in human cancer. Nature 1994; 372: 143–149
   PubMed Web of Science ®Google Scholar
• Bishop J M. Molecular themes in oncogenesis 1991; 64: 235–248
   Google Scholar
• Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H, Murakami Y, Hayashi K, Saito H. Mutations of p53 gene and their relation to disease progression in B-Cell Lymphoma. Blood 1992; 79: 2701–2707
   PubMed Web of Science ®Google Scholar